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IN MEMORIAM
Calvin Jackson Dillaha was born in Little Rock, Arkansas, on June 20, 1924.
He attended Little Rock Junior College and received his medical degree from
the University of Arkansas. Following his internship at the Scott & White Clinic
in Temple, Texas, his early interest and enthusiasm for dermatology was pur-
sued, and he completed his post-graduate training at the University of Chicago
under Steven Rothman, M.D.
Dr. Dillaha's boundless zeal could not be fulfilled in his practice efforts alone,
and under his guidance an active dermatology program was developed at the
University of Arkansas. His own interest in research, as nurtured by Dr. Roth-
man, prompted an active clinical and investigative program at the Little Rock
Veterans Administration Hospital, as well as the University of Arkansas Medi-
cal Center. He had an ardent belief that his own research interests should have
an immediate goal of improving patient care. This was exemplified by his inter-
est in the treatment of alopecia areata with corticosteroids, treatment of acro-
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dermatitis enteropathica with diodoquin, and his more recent contributions to
the recognition of the necrotic bite of the Brown Recluse Spider and the charac-
terization of its venom.
His most significant contributions, however, were related to the recognition
of 5-fluorouracil as an active agent in the treatment of actinie keratoses. For
this work he received the first achievement award of the Dermatology Founda-
tion.
At the time of his death on January 9, 1969, at the age of 44, he was a member
of the Board of Directors of the Academy of Dermatology, and The Society of
Investigative Dermatology. His interests were not limited to dermatology
alone, and he was recognized for his influence in the general medical community
and the business community of Little Rock.
He is survived by his wife, Patty Lou, and four children, Marcia, Melissa,
Jennifer and Martin. It is anticipated that the accomplishments of Dr. Dillaha,
in so short a time, in spite of a chronic disabling illness, will act as an inspira-
tion to all of us, especially those interested in a close and profitable union be-
tween the investigator and the clinician.
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